ROLE OF CD26 DIPEPTIDYL PEPTIDASE-IV IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND APOPTOSIS/

Citation
C. Morimoto et al., ROLE OF CD26 DIPEPTIDYL PEPTIDASE-IV IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION AND APOPTOSIS/, Proceedings of the National Academy of Sciences of the United Statesof America, 91(21), 1994, pp. 9960-9964
Citations number
41
Categorie Soggetti
Multidisciplinary Sciences
ISSN journal
00278424
Volume
91
Issue
21
Year of publication
1994
Pages
9960 - 9964
Database
ISI
SICI code
0027-8424(1994)91:21<9960:ROCDPI>2.0.ZU;2-7
Abstract
To examine the role of CD26/dipeptidyl peptidase IV (DPPIV; EC 3.4.14. 5) in infection by human immunodeficiency virus type 1 (HIV-1), we uti lized CD26 cDNA-transfected Jurkat T-cell lines. Both CD26(-) parental Jurkat cells and mutant CD26(+) (DPPIV-) transfected Jurkat cells wer e readily infected with HIV-1, whereas wild-type CD26(+) (DPPIV+) tran sfected Jurkat cells were more resistant to HIV-1 infection. Our resul ts suggest that CD26 is not essential for HIV-1 infectivity as suggest ed by others but that DPPIV enzyme activity may decrease the efficienc y of HIV-1 infection, Of great interest, we found that mutant CD26(+) (DPPIV-) transfectants and CD26(-) parental Jurkat cells strongly expr essed CD95 (Fas/Apo-1) and were more sensitive than wild-type CD26(+) (DPPIV+) transfectants to the induction of apoptosis by anti-CD95 mono clonal antibody. These results suggest that CD26 may play a role in HI V-1-associated loss of CD4(+) cells through the process of programmed cell death.